| |
 |
|
 |
 |
 |
- Objective:
Transformation of new treatment concepts into patent protected and marketable drug candidates with phase II clinical proof-of-concept data.
- Selection criteria for a new concept:
- Gender-related disease
- Patentable
- Medical need
- Marketing opportunity
- Established saftey record
- Pharmaceutical formulation possible
- Business:
Creation of a patent protected phase II portfolio for outlicensing to third parties for phase III development and commercialisation.
- Organisation:
Pantarhei Bioscience is organised as a project management organisation outsourcing its drug development activities.
|
 |
| Copyright © Pantarhei
Bioscience 2008 | Disclaimer |
|